Swells in the form of publicity from the groundbreaking Q-Symbio study where CoQ10 was given to severe heart disease patients, continue to roll across the globe. The latest example of this is an article from the Huffington Post.
Biggest news of the conference was the presentation of the results of the Q-Symbio study, a double-blind placebo-controlled clinical trial.
Science-based Supplements finally to enter the US Market
The CoQ10 treatment group shows 43% reduced complications and deaths as compared to the placebo group.
Seniors get improved quality of life with dietary supplements. Both the quality of life and life expectancy can be improved, a large Swedish study shows.